liquid biopsy, precision oncology, ctDNA (circulating tumor DNA), Circulating molecular marker, personalized medicine
dx.doi.org/10.3389/fphar.2020.598261, hdl.handle.net/1765/131409
Frontiers in Pharmacology
Department of Clinical Chemistry

Ravegnini, G., Del Re, M, Grolla, A.A., van Schaik, R.H.N, & Angelini, S. (2020). Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.598261